VMPL
Jerusalem (Israel), August 17: G Medical Innovations, a cutting edge mobile health company, proudly announces the appointment of Akash Biomatrix Pvt. Ltd as the exclusive master distributor for its flagship product PRIZMA in India. This strategic partnership marks a significant milestone in the advancement of healthcare technology.
PRIZMA: A revolution in remote health monitoring
A portable, FDA-approved device, PRIZMA provides users with the ability to wirelessly monitor key vital signs in real time, including:
1. ECG (Electrocardiogram): Measures the heart's electrical impulses and helps diagnose abnormal heart rhythms such as atrial fibrillation.
2. Blood Pressure: Provides accurate blood pressure readings.
3. Blood Sugar (Glucose): Monitor blood sugar levels for diabetes management.
4. SPo2 (Oxygen Saturation): Tracks the oxygen levels in your blood.
Main features of PRIZMA:
* Waterproof AI Patches: These small waterproof patches are applied to the user's chest and transmit data 24/7 to PRIZMA devices and remote diagnostic centers – no patient cables required.
* Real-time remote diagnosis: AI-enabled algorithms analyze data and provide early warning and alerts for signs of cardiovascular events.
* User-friendly: PRIZMA is easy to apply and does not require mobile phone pairing.
* Certified Cardiac Technicians: Continuous monitoring by certified cardiac technicians ensures accurate analysis.
* Multi-Channel ECG: PRIZMA's multi-channel enhanced Holter records every heartbeat, enhancing diagnostic accuracy.
* Higher patient compliance: Comfortable, stress-free monitoring promotes patient compliance.
Saving Lives, One Alarm at a Time
PRIZMA has the potential to save countless lives through early detection of cardiovascular events. The future of remote health monitoring is here, and G Medical Innovations and Akash Biomatrix are at the forefront.
Prizma Care – An innovative ecosystem for remote patient monitoring
An innovative ecosystem that can save lives by remotely and reliably monitoring patient vital signs, detecting and notifying abnormalities in heart rate, ECG, blood pressure, oxygen saturation and weight, enabling timely intervention and prevention.
G Medical G Patch
FDA-approved pediatric and adult G-Patch (AECG) is proven to increase patient comfort and compliance. “Snap-on, peel-off, stick” application allows stress-free monitoring. Ultra-compact design and comfortable format increase patient compliance. Wearable for 72 hours up to 14 days, it continuously records 2- or 3-channel ECG.
Potential market size for personal portable medical diagnostics in India
The personal portable medical diagnostics segment in India shows great potential due to health-conscious consumers and technological advancements.
1. Market size: In 2023, the Indian diagnostics market was valued at $13 billion and is projected to reach $26 billion by 2028.
2. Growth drivers: Chronic diseases, ageing population and increasing health consciousness are driving growth.
3. Forecast: The Indian diagnostic lab market is expected to reach $44.92 billion by 2032, with another estimate predicting it will reach $20 billion by 2026.
Dr. Yakov Geva, CEO, G Medical Innovations expressed his enthusiasm about the collaboration saying, “Our mission is to transform healthcare through innovative solutions. With Akash Biomatrix's expertise and reach in India, PRIZMA will empower both patients and healthcare providers.”
Niv Geva said, “We at G Medical Innovations are excited to distribute Prisma in South Asia, particularly the multi-billion dollar market of India.”
Dr Yakov Geva added: “Even if we capture a small market share in India, it will translate into hundreds of millions of dollars in revenue.”
About G Medical Innovations: G Medical Innovations is a next-generation mobile health company that develops and sells clinical and consumer medical-grade health monitoring solutions and provides end-to-end support for e-health projects.
For more information, please visit G Medical Innovations or PRIZMACare23.
About Akash Biomatrix Pvt. Ltd: Akash Biomatrix Pvt. Ltd, headquartered in Mumbai, India, is a leading healthcare solutions provider committed to improving patient outcomes through cutting-edge technology.
For any media enquiries please contact: Press Relations Email: [email protected], [email protected] Mobile: +91-9137371062, +91-9359781225
Disclaimer: This press release is for informational purposes only and does not constitute medical advice.
Note: This press release contains forward-looking statements. Actual results may vary depending on market conditions and regulatory approvals.
(Advertisement Disclaimer: The above press release has been provided by VMPL. ANI is not responsible or liable for its content)
Disclaimer: Business Standard journalists have not been involved in the creation of this content.
First Published: 17 August 2024 | 4:20 PM IST
